ArticleScientific reports2024
Enhancing shielding efficiency of ordinary and barite concrete in radiation shielding utilizations.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Influence of High-Z Filler Chemistry on the Energy-Dependent Gamma-Ray Shielding of Cement-Board Composites.Materials (Basel, Switzerland) · 2026Article
- Multi-analytical characterization and radiation shielding assessment of natural ophiolitic rocks: a combined experimental, mineralogical, and simulation analysis.Scientific reports · 2026Article
- Experimental Investigation of Mechanical Performance and Gamma Radiation Shielding of Hybrid Magnetite-Dolomite High-Density Concrete.Materials (Basel, Switzerland) · 2026Article
- Radiation shielding and hydro-mechanical performance of bentonite-copper slag mixtures.Scientific reports · 2026Article
- Integrated mineralogical, microstructural, and thermal characterization of Azara barite Nasarawa State, Nigeria and its implications for radiation shielding materials.Scientific reports · 2026Article
- Effects of type and thickness of joint infill materials on gamma radiation attenuation in rock masses: experimental and numerical investigations.Scientific reports · 2026Article
- Durability and radiation shielding performance of blended cement mortar under increased ambient temperature and sulfate exposure in arid environments.Scientific reports · 2025Article
- Design and evaluation of carbon fabric/epoxy reinforced with reduced graphene oxide (RGO) hybrid composite for gamma ray shielding.RSC advances · 2025Article
- Structural, thermal and X-ray shielding properties of basalt and glass fiber reinforced epoxy composites.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Concrete has been widely utilized as a radiation shielding material due to its properties and structural integrity. This study aims to evaluate the efficiency of ordinary concrete versus barite concrete as radiation shielding materials, focusing on the physical aspects and changes in crystal size lattice parameters after neutron irradiation. Specifically, the research investigates the shielding effectiveness of these materials across different grades (M15, M25, M35, and M45) against gamma-ray sources Cobalt-60 and Caesium-137. The methodology involves measuring the linear attenuation coefficient (μ), half value layer (HVL), tenth value layer (TVL), and mean free path (MFP). Additionally, X-ray diffraction (XRD) was employed to assess crystallite size and lattice parameter changes post-irradiation for neutron irradiation. Results indicate that incorporating barite as an aggregate significantly enhances the density and crystallite macroscopic properties of the concrete. Irradiation with Cobalt-60 and Cesium 137 revealed that ordinary concrete has a lower linear attenuation (μ) ranging from 0.172 to 0.195 cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.